Cargando…

Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates?

BACKGROUND: In the last decades, human full-term cord blood was extensively investigated as a potential source of hematopoietic stem and progenitor cells (HSPCs). Despite the growing interest of regenerative therapies in preterm neonates, only little is known about the biological function of HSPCs f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wisgrill, Lukas, Schüller, Simone, Bammer, Markus, Berger, Angelika, Pollak, Arnold, Radke, Teja Falk, Kögler, Gesine, Spittler, Andreas, Helmer, Hanns, Husslein, Peter, Gortner, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152327/
https://www.ncbi.nlm.nih.gov/pubmed/25181353
http://dx.doi.org/10.1371/journal.pone.0106717
_version_ 1782333126590070784
author Wisgrill, Lukas
Schüller, Simone
Bammer, Markus
Berger, Angelika
Pollak, Arnold
Radke, Teja Falk
Kögler, Gesine
Spittler, Andreas
Helmer, Hanns
Husslein, Peter
Gortner, Ludwig
author_facet Wisgrill, Lukas
Schüller, Simone
Bammer, Markus
Berger, Angelika
Pollak, Arnold
Radke, Teja Falk
Kögler, Gesine
Spittler, Andreas
Helmer, Hanns
Husslein, Peter
Gortner, Ludwig
author_sort Wisgrill, Lukas
collection PubMed
description BACKGROUND: In the last decades, human full-term cord blood was extensively investigated as a potential source of hematopoietic stem and progenitor cells (HSPCs). Despite the growing interest of regenerative therapies in preterm neonates, only little is known about the biological function of HSPCs from early preterm neonates under different perinatal conditions. Therefore, we investigated the concentration, the clonogenic capacity and the influence of obstetric/perinatal complications and maternal history on HSPC subsets in preterm and term cord blood. METHODS: CD34+ HSPC subsets in UCB of 30 preterm and 30 term infants were evaluated by flow cytometry. Clonogenic assays suitable for detection of the proliferative potential of HSPCs were conducted. Furthermore, we analyzed the clonogenic potential of isolated HSPCs according to the stem cell marker CD133 and aldehyde dehydrogenase (ALDH) activity. RESULTS: Preterm cord blood contained a significantly higher concentration of circulating CD34+ HSPCs, especially primitive progenitors, than term cord blood. The clonogenic capacity of HSPCs was enhanced in preterm cord blood. Using univariate analysis, the number and clonogenic potential of circulating UCB HSPCs was influenced by gestational age, birth weight and maternal age. Multivariate analysis showed that main factors that significantly influenced the HSPC count were maternal age, gestational age and white blood cell count. Further, only gestational age significantly influenced the clonogenic potential of UCB HSPCs. Finally, isolated CD34+/CD133+, CD34+/CD133– and ALDH(high) HSPC obtained from preterm cord blood showed a significantly higher clonogenic potential compared to term cord blood. CONCLUSION: We demonstrate that preterm cord blood exhibits a higher HSPC concentration and increased clonogenic capacity compared to term neonates. These data may imply an emerging use of HSPCs in autologous stem cell therapy in preterm neonates.
format Online
Article
Text
id pubmed-4152327
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41523272014-09-05 Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates? Wisgrill, Lukas Schüller, Simone Bammer, Markus Berger, Angelika Pollak, Arnold Radke, Teja Falk Kögler, Gesine Spittler, Andreas Helmer, Hanns Husslein, Peter Gortner, Ludwig PLoS One Research Article BACKGROUND: In the last decades, human full-term cord blood was extensively investigated as a potential source of hematopoietic stem and progenitor cells (HSPCs). Despite the growing interest of regenerative therapies in preterm neonates, only little is known about the biological function of HSPCs from early preterm neonates under different perinatal conditions. Therefore, we investigated the concentration, the clonogenic capacity and the influence of obstetric/perinatal complications and maternal history on HSPC subsets in preterm and term cord blood. METHODS: CD34+ HSPC subsets in UCB of 30 preterm and 30 term infants were evaluated by flow cytometry. Clonogenic assays suitable for detection of the proliferative potential of HSPCs were conducted. Furthermore, we analyzed the clonogenic potential of isolated HSPCs according to the stem cell marker CD133 and aldehyde dehydrogenase (ALDH) activity. RESULTS: Preterm cord blood contained a significantly higher concentration of circulating CD34+ HSPCs, especially primitive progenitors, than term cord blood. The clonogenic capacity of HSPCs was enhanced in preterm cord blood. Using univariate analysis, the number and clonogenic potential of circulating UCB HSPCs was influenced by gestational age, birth weight and maternal age. Multivariate analysis showed that main factors that significantly influenced the HSPC count were maternal age, gestational age and white blood cell count. Further, only gestational age significantly influenced the clonogenic potential of UCB HSPCs. Finally, isolated CD34+/CD133+, CD34+/CD133– and ALDH(high) HSPC obtained from preterm cord blood showed a significantly higher clonogenic potential compared to term cord blood. CONCLUSION: We demonstrate that preterm cord blood exhibits a higher HSPC concentration and increased clonogenic capacity compared to term neonates. These data may imply an emerging use of HSPCs in autologous stem cell therapy in preterm neonates. Public Library of Science 2014-09-02 /pmc/articles/PMC4152327/ /pubmed/25181353 http://dx.doi.org/10.1371/journal.pone.0106717 Text en © 2014 Wisgrill et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wisgrill, Lukas
Schüller, Simone
Bammer, Markus
Berger, Angelika
Pollak, Arnold
Radke, Teja Falk
Kögler, Gesine
Spittler, Andreas
Helmer, Hanns
Husslein, Peter
Gortner, Ludwig
Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates?
title Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates?
title_full Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates?
title_fullStr Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates?
title_full_unstemmed Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates?
title_short Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates?
title_sort hematopoietic stem cells in neonates: any differences between very preterm and term neonates?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152327/
https://www.ncbi.nlm.nih.gov/pubmed/25181353
http://dx.doi.org/10.1371/journal.pone.0106717
work_keys_str_mv AT wisgrilllukas hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT schullersimone hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT bammermarkus hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT bergerangelika hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT pollakarnold hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT radketejafalk hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT koglergesine hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT spittlerandreas hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT helmerhanns hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT hussleinpeter hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates
AT gortnerludwig hematopoieticstemcellsinneonatesanydifferencesbetweenverypretermandtermneonates